Protective effects of dietary phytoestrogens in chronic renal disease

2001 ◽  
Vol 11 (4) ◽  
pp. 183-193 ◽  
Author(s):  
Tedine Ranich ◽  
Sam J. Bhathena ◽  
Manuel T. Velasquez
2001 ◽  
Vol 11 (4) ◽  
pp. 183-193 ◽  
Author(s):  
Tedine Ranich ◽  
Sam J. Bhathena ◽  
Manuel T. Velasquez

1970 ◽  
Vol 126 (5) ◽  
pp. 774-780 ◽  
Author(s):  
A. J. Erslev

1971 ◽  
Author(s):  
Virgil Smirnow ◽  
Robert J. Shaloub ◽  
Jonathan W. Cummings ◽  
Vincent Glaudin ◽  
Roy Brener ◽  
...  

2001 ◽  
Vol 21 (1) ◽  
pp. 3-12 ◽  
Author(s):  
Amin Al-Ahmad ◽  
Mark J. Sarnak ◽  
Deeb N. Salem ◽  
Marvin A. Konstam

1980 ◽  
Vol 19 (04) ◽  
pp. 205-209
Author(s):  
L. A. Abbott ◽  
J. B. Mitton

Data taken from the blood of 262 patients diagnosed for malabsorption, elective cholecystectomy, acute cholecystitis, infectious hepatitis, liver cirrhosis, or chronic renal disease were analyzed with three numerical taxonomy (NT) methods : cluster analysis, principal components analysis, and discriminant function analysis. Principal components analysis revealed discrete clusters of patients suffering from chronic renal disease, liver cirrhosis, and infectious hepatitis, which could be displayed by NT clustering as well as by plotting, but other disease groups were poorly defined. Sharper resolution of the same disease groups was attained by discriminant function analysis.


1951 ◽  
Vol 8 (2) ◽  
pp. 165-174
Author(s):  
SVEN JOHNSSON ◽  
ROLF LUFT ◽  
BJÖRN SJÖGREN ◽  
JAN WALDENSTRÖM

2008 ◽  
Vol 149 (15) ◽  
pp. 691-696
Author(s):  
Dániel Bereczki

Chronic kidney diseases and cardiovascular diseases have several common risk factors like hypertension and diabetes. In chronic renal disease stroke risk is several times higher than in the average population. The combination of classical risk factors and those characteristic of chronic kidney disease might explain this increased risk. Among acute cerebrovascular diseases intracerebral hemorrhages are more frequent than in those with normal kidney function. The outcome of stroke is worse in chronic kidney disease. The treatment of stroke (thrombolysis, antiplatelet and anticoagulant treatment, statins, etc.) is an area of clinical research in this patient group. There are no reliable data on the application of thrombolysis in acute stroke in patients with chronic renal disease. Aspirin might be administered. Carefulness, individual considerations and lower doses might be appropriate when using other treatments. The condition of the kidney as well as other associated diseases should be considered during administration of antihypertensive and lipid lowering medications.


Sign in / Sign up

Export Citation Format

Share Document